Literature DB >> 81635

Levamisole and inosiplex: antiviral agents with immunopotentiating action.

J W Hadden, C Lopez, R J O'Reilly, E M Hadden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 81635     DOI： 10.1111/j.1749-6632.1977.tb21945.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Effect of immunomodulating agents on leucocyte chemotaxis and cyclic nucleotides.

Authors:  M Roch-Arveiller; M Tissot; L Moachon; J P Giroud
Journal:  Agents Actions       Date:  1982-07

2.  Mechanism of host defense suppression induced by viral infection: mode of action of inosiplex as an antiviral agent.

Authors:  H Ohnishi; H Kosuzume; H Inaba; M Okura; Y Morita; H Mochizuki; Y Suzuki
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

3.  Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS).

Authors:  P H Tsang; K Tangnavarad; S Solomon; J G Bekesi
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

Review 4.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

5.  Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (MPro).

Authors:  Khalil El Khatabi; Ilham Aanouz; Marwa Alaqarbeh; Mohammed Aziz Ajana; Tahar Lakhlifi; Mohammed Bouachrine
Journal:  Bioimpacts       Date:  2021-10-02

Review 6.  Diagnosis of viral disease and the advent of antiviral drugs.

Authors:  E C Herrmann; J A Herrmann
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.